150 related articles for article (PubMed ID: 15585502)
1. Antimicrobial susceptibility testing of vancomycin-resistant Enterococcus by the VITEK 2 system, and comparison with two NCCLS reference methods.
Kobayashi I; Muraoka H; Iyoda T; Nishida M; Hasegawa M; Yamaguchi K
J Med Microbiol; 2004 Dec; 53(Pt 12):1229-1232. PubMed ID: 15585502
[TBL] [Abstract][Full Text] [Related]
2. Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin.
Kohner PC; Patel R; Uhl JR; Garin KM; Hopkins MK; Wegener LT; Cockerill FR
J Clin Microbiol; 1997 Dec; 35(12):3258-63. PubMed ID: 9399530
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.
van Den Braak N; Goessens W; van Belkum A; Verbrugh HA; Endtz HP
J Clin Microbiol; 2001 Jan; 39(1):351-3. PubMed ID: 11136798
[TBL] [Abstract][Full Text] [Related]
4. Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.
Jones ME; Gesu G; Ortisi G; Sahm DF; Critchley IA; Goglio A;
Clin Microbiol Infect; 2002 Feb; 8(2):101-11. PubMed ID: 11952723
[TBL] [Abstract][Full Text] [Related]
5. Validation of VITEK 2 version 4.01 software for detection, identification, and classification of glycopeptide-resistant enterococci.
Abele-Horn M; Hommers L; Trabold R; Frosch M
J Clin Microbiol; 2006 Jan; 44(1):71-6. PubMed ID: 16390951
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiological study on vancomycin-resistant enterococci from fecal samples in the east area of Japan].
Oguri T; Misawa S; Nakamura A; Igari J; Ishii Y; Yamaguchi K
Kansenshogaku Zasshi; 2001 Jul; 75(7):541-50. PubMed ID: 11521276
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci.
Garcia-Garrote F; Cercenado E; Bouza E
J Clin Microbiol; 2000 Jun; 38(6):2108-11. PubMed ID: 10834961
[TBL] [Abstract][Full Text] [Related]
8. [Laboratory-evaluation of antimicrobial susceptibility testings to detect vancomycin-resistant enterococci].
Yamane N; Miyagawa S; Nakasone I; Sakamoto F; Tosaka M
Rinsho Byori; 1997 Apr; 45(4):381-90. PubMed ID: 9136603
[TBL] [Abstract][Full Text] [Related]
9. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci.
Tenover FC; Swenson JM; O'Hara CM; Stocker SA
J Clin Microbiol; 1995 Jun; 33(6):1524-7. PubMed ID: 7650179
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
[TBL] [Abstract][Full Text] [Related]
11. A rapid antimicrobial susceptibility test based on chemiluminescence assay and its application to screening of genotypes in vancomycin-resistant enterococci.
Nagasawa Z; Manome I; Nagayama A
J Infect Chemother; 2004 Aug; 10(4):220-6. PubMed ID: 15365863
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of staphylococci and enterococci to glycopeptides comparison of 3 test methods.
Jansen B; Schumacher-Perdreau F; Pulverer G
Zentralbl Bakteriol; 1995 Oct; 282(4):402-8. PubMed ID: 9810663
[TBL] [Abstract][Full Text] [Related]
13. Performance of the EUCAST disk diffusion method, the CLSI agar screen method, and the Vitek 2 automated antimicrobial susceptibility testing system for detection of clinical isolates of Enterococci with low- and medium-level VanB-type vancomycin resistance: a multicenter study.
Hegstad K; Giske CG; Haldorsen B; Matuschek E; Schønning K; Leegaard TM; Kahlmeter G; Sundsfjord A;
J Clin Microbiol; 2014 May; 52(5):1582-9. PubMed ID: 24599985
[TBL] [Abstract][Full Text] [Related]
14. [Drug resistance of 100 clinical strains of Enterococcus spp].
Sawicka-Grzelak A; Rokosz A; Luczak M
Med Dosw Mikrobiol; 1999; 51(3-4):239-47. PubMed ID: 10803253
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the vitek gram-positive susceptibility system's detection of vanB-encoded vancomycin resistance among enterococci.
Jett B; Free L; Sahm DF
J Clin Microbiol; 1996 Mar; 34(3):701-6. PubMed ID: 8904441
[TBL] [Abstract][Full Text] [Related]
16. Comparison of eight methods to detect vancomycin resistance in enterococci.
Endtz HP; Van Den Braak N; Van Belkum A; Goessens WH; Kreft D; Stroebel AB; Verbrugh HA
J Clin Microbiol; 1998 Feb; 36(2):592-4. PubMed ID: 9466786
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China.
Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE
Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.
Williams JD; Maskell JP; Whiley AC; Sefton AM
J Antimicrob Chemother; 1997 May; 39 Suppl A():41-6. PubMed ID: 9511061
[TBL] [Abstract][Full Text] [Related]
19. [Detection of antibiotic resistance in Enterococcus sp. Comparison of GPS-TA (BioMérieux-Vitek), Uniscept MIC-3 (bioMérieux-Vitek) and conventional methods].
Alamo I; González A
Enferm Infecc Microbiol Clin; 1995 Nov; 13(9):516-21. PubMed ID: 8519833
[TBL] [Abstract][Full Text] [Related]
20. Analysis of methods commonly used for glycopeptide and oxazolidinone susceptibility testing in Enterococcus faecium isolates.
Raponi G; Ghezzi MC; Gherardi G; Lorino G; Dicuonzo G
J Med Microbiol; 2010 Jun; 59(Pt 6):672-678. PubMed ID: 20185550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
